UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity

Journal of the American Academy of Dermatology, 2017-05, Vol.76 (5), p.847-855.e5

2017

Link zum Volltext

Verfügbarkeit prüfen

Resident Memory T Cells in Autoimmune Skin Diseases

Frontiers in immunology, 2021-05, Vol.12, p.652191-652191

2021

Link zum Volltext

Verfügbarkeit prüfen

Regulation of Cellular Processes by Interleukin-16 in Homeostasis and Cancer

Journal of cellular physiology, 2014-02, Vol.229 (2), p.139-147

2014

Link zum Volltext

Verfügbarkeit prüfen

CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo

Science translational medicine, 2014-02, Vol.6 (223), p.223ra23

2014

Link zum Volltext

Verfügbarkeit prüfen

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo

Science translational medicine, 2018-07, Vol.10 (450)

2018

Link zum Volltext

Verfügbarkeit prüfen

CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice

Journal of investigative dermatology, 2017-04, Vol.137 (4), p.982-985

2017

Link zum Volltext

Verfügbarkeit prüfen

Innate immune mechanisms in vitiligo: danger from within

Current opinion in immunology, 2013-12, Vol.25 (6), p.676-682

2013

Link zum Volltext

Verfügbarkeit prüfen

Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma

PloS one, 2023-08, Vol.18 (8), p.e0290428-e0290428

2023

Link zum Volltext

Verfügbarkeit prüfen

Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo

Journal of investigative dermatology, 2019-04, Vol.139 (4), p.769-778

2019

Link zum Volltext

Verfügbarkeit prüfen

IL-12/IL-23–Independent Function of BATF3-Dependent Dendritic Cells Is Required for Initiation of Disease in a Mouse Model of Vitiligo

Journal of investigative dermatology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Immunology and skin in health and disease

Cold Spring Harbor perspectives in medicine, 2014-12, Vol.4 (12), p.a015339-a015339

2014

Link zum Volltext

Verfügbarkeit prüfen

Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease

Journal of investigative dermatology, 2017-02, Vol.137 (2), p.350-358

2017

Link zum Volltext

Verfügbarkeit prüfen

Jak Inhibitors Reverse Vitiligo in Mice but Do Not Deplete Skin Resident Memory T Cells

Journal of investigative dermatology, 2021-01, Vol.141 (1), p.182-184.e1

2021

Link zum Volltext

Verfügbarkeit prüfen

T‐cell positioning by chemokines in autoimmune skin diseases

Immunological reviews, 2019-05, Vol.289 (1), p.186-204

2019

Link zum Volltext

Verfügbarkeit prüfen

Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy

Pigment cell and melanoma research, 2021-07, Vol.34 (4), p.683-695

2021

Link zum Volltext

Verfügbarkeit prüfen

Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo

Journal of investigative dermatology, 2015-04, Vol.135 (4), p.1080-1088

2015

Link zum Volltext

Verfügbarkeit prüfen

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis

Frontiers in immunology, 2020-07, Vol.11, p.1353-1353

2020

Link zum Volltext

Verfügbarkeit prüfen

Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus-Like Inflammation

Frontiers in immunology, 2022-06, Vol.13, p.883375-883375

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update

Expert review of clinical immunology, 2022-03, Vol.18 (3), p.263-272

2022

Link zum Volltext

Verfügbarkeit prüfen

Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases [version 1; peer review: 2 approved]

F1000 research, 2020, Vol.9, p.1197-1197

2020

Link zum Volltext

Verfügbarkeit prüfen

A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo

Journal of the American Academy of Dermatology, 2017-01, Vol.76 (1), p.150-151.e3

2017

Link zum Volltext

Verfügbarkeit prüfen

Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders

Frontiers in immunology, 2020-12, Vol.11, p.590558-590558

2020

Link zum Volltext

Verfügbarkeit prüfen

A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.3294-3303

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunopathogenesis of alopecia areata

Current research in immunology, 2021-01, Vol.2, p.7-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Mouse Model for Human Vitiligo

Current Protocols in Immunology, 2019-02, Vol.124 (1), p.e63-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(101)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity

Resident Memory T Cells in Autoimmune Skin Diseases

Regulation of Cellular Processes by Interleukin-16 in Homeostasis and Cancer

CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo

CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice

Innate immune mechanisms in vitiligo: danger from within

Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma

Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo

IL-12/IL-23–Independent Function of BATF3-Dependent Dendritic Cells Is Required for Initiation of Disease in a Mouse Model of Vitiligo

Immunology and skin in health and disease

Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease

Jak Inhibitors Reverse Vitiligo in Mice but Do Not Deplete Skin Resident Memory T Cells

T‐cell positioning by chemokines in autoimmune skin diseases

Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy

Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis

Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus-Like Inflammation

Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update

Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases [version 1; peer review: 2 approved]

A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo

Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders

A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo

Immunopathogenesis of alopecia areata

Mouse Model for Human Vitiligo

Suchergebnisse filtern